This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Why Jim Cramer Says Buy Pinnacle Foods (PF) But Avoid AstraZeneca (AZN) Stock

NEW YORK (TheStreet) -- TheStreet's Jim Cramer says there was an undercurrent when Hillshire Brands (HSH) bought Pinnacle Foods (PF - Get Report) that another entity was about to swoop in and acquire Hillshire. It appears that may have in fact been the case, as Pilgrim's Pride (PPC - Get Report) came out of nowhere with an extremely high bid for Hillshire.

The question now is what do to with Pinnacle, and Cramer believes the stock was doing quite well and is now down approximately 10% in the wake of the news. He says this creates an opportunity to pick up Pinnacle, which looks "jilted."

Cramer does not feel the same way, though, about AstraZeneca (AZN - Get Report), which Pfizer (PFE - Get Report) jilted by refusing to raise its takeover bid any higher after the British pharmaceutical company fought it tooth and nail. Cramer does not like AstraZeneca's pipeline or prospects and urges investors to stay away.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Must Read: Jim Cramer Says Buy Pinnacle Foods, Stay Away from AstraZeneca

PF Chart

PF data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

WATCH: More videos from Jim Cramer on TheStreet TV

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AZN $29.28 1.10%
HSH $62.96 0.00%
PPC $27.50 2.20%
PFE $32.79 0.24%
PF $42.61 0.05%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs